We are a multidisciplinary team working to advance epidemiological knowledge of endemic, emerging and pandemic infections. Our priority is understanding inequalities in infection burden for clinical and population health action. To this end, we use observational and interventional epidemiological study designs and novel and emerging data sources.

We are undertaking research to improve the effectiveness of current vaccines and drive the development of new vaccines for major diseases of humans and animals. Our vaccine research spans a wide range of viral, bacterial, and parasite infections.

We develop and use clinically relevant in vitro and in vivo models of respiratory, gastrointestinal, brain and systemic infection to elucidate mechanistic understanding of bacterial and viral disease processes and host immune responses. Our models include a wide range of primary and cell line tissue culture models, organoid models, and Galleria, zebrafish and mouse models of infectious disease.

We specialise in studying host-pathogen interactions with our expertise spanning an array of bacterial and viral pathogens. We implement our studies across multiple platforms, including animal models, and human subjects. Our studies are aimed at developing interventions, that encompass diagnostics, pioneering therapeutics targeting resistant pathogens, combating emerging or re-emerging infections, and advancing vaccine development.